Wirth MP - Search Results

1

Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.

Schindler A, Fiedler U, Meye A, Schmidt U, Füssel S, Pilarsky C, Herrmann J, Wirth MP. Schindler A, et al. Among authors: wirth mp. Int J Oncol. 2001 Jul;19(1):25-30. Int J Oncol. 2001. PMID: 11408918

2

[The value of prostate-specific antigen in therapy follow-up of prostatic carcinoma].

Wirth MP, Pilarsky C. Wirth MP, et al. Urologe A. 1995 Jul;34(4):297-302. Urologe A. 1995. PMID: 7545844 Review. German.

3

The effect of tumor necrosis factor alpha on a human renal cell carcinoma xenotransplanted into nude mice: comparison of intravenous and intraperitoneal injection.

Hofmockel G, Bassukas ID, Heimbach D, Metz R, Wirth MP. Hofmockel G, et al. Among authors: wirth mp. Oncology. 1995 Jan-Feb;52(1):69-75. doi: 10.1159/000227431. Oncology. 1995. PMID: 7800346

4

Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma.

Froschermaier SE, Pilarsky CP, Wirth MP. Froschermaier SE, et al. Among authors: wirth mp. Urology. 1996 Apr;47(4):525-8. doi: 10.1016/S0090-4295(99)80488-9. Urology. 1996. PMID: 8638361

5

Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.

Manseck A, Pilarsky C, Froschermaier S, Menschikowski M, Wirth MP. Manseck A, et al. Among authors: wirth mp. Urol Int. 1998;60(1):25-7. doi: 10.1159/000030198. Urol Int. 1998. PMID: 9519417 Clinical Trial.

6

Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer.

Pilarsky CP, Schmidt U, Eissrich C, Stade J, Froschermaier SE, Haase M, Faller G, Kirchner TW, Wirth MP. Pilarsky CP, et al. Among authors: wirth mp. Prostate. 1998 Jul 1;36(2):85-91. doi: 10.1002/(sici)1097-0045(19980701)36:2<85::aid-pros3>3.0.co;2-d. Prostate. 1998. PMID: 9655260

7

Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1.

Schmidt U, Fiedler U, Pilarsky CP, Ehlers W, Füssel S, Haase M, Faller G, Sauter G, Wirth MP. Schmidt U, et al. Among authors: wirth mp. Prostate. 2001 May 1;47(2):91-101. doi: 10.1002/pros.1051. Prostate. 2001. PMID: 11340631

8

[Gene therapy and immunotherapy in prostatic carcinoma].

Fiedler U, Wirth MP. Fiedler U, et al. Among authors: wirth mp. Urologe A. 2001 May;40(3):207-16. doi: 10.1007/s001200050464. Urologe A. 2001. PMID: 11405130 Review. German.

9

LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.

Fiedler U, Ehlers W, Meye A, Füssel S, Faller G, Schmidt U, Wirth MP. Fiedler U, et al. Among authors: wirth mp. Anticancer Res. 2001 Jul-Aug;21(4A):2341-50. Anticancer Res. 2001. PMID: 11724291

10

Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.

Meye A, Bilkenroth U, Schmidt U, Füssel S, Robel K, Melchior AM, Blümke K, Pinkert D, Bartel F, Linne C, Taubert H, Wirth MP. Meye A, et al. Among authors: wirth mp. Int J Oncol. 2002 Sep;21(3):521-30. Int J Oncol. 2002. PMID: 12168095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters